AN OPEN-LABEL TRIAL ASSESSING THE OPTIMAL DOSE EFFICACY AND SAFETY OF GBM-5 IN THE TREATMENT OF PAIN ASSOCIATED WITH COMPLEX REGIONAL PAIN SYNDROME

Registry ID
MEDNC-001
Source registry
HEALTH_CANADA
Status
Pending
Study type
INTERVENTIONAL
Sponsor
GILBERT BLAISE INC
Last update
2019-10-16

Conditions

Related clinical trials

View on source registry